Health ❯ Healthcare ❯ Cardiology

Heart Disease

Heart Attack Risk Factors Heart Failure Cholesterol Management LDL Cholesterol Risk Assessment Prevention Strategies Treatment Options Mortality Rates Myocardial Infarction Treatment Prevention Inflammation Coronary Artery Disease Women’s Health Coronary Artery Bypass Grafting Sleep Patterns Blood Pressure Management Aldosterone Dysregulation Mitral Regurgitation Heart Attack Treatment Diagnostic Tools Atrial Fibrillation Ischemia Aortic Stenosis Hypertension Artificial Intelligence Disease Progression Protein Function Heart Attacks Heart Regeneration Ischemic Heart Disease Alcoholism Aung San Suu Kyi Dilated Cardiomyopathy Acute Heart Failure Cardiac Remodeling Light Exposure Effects Statistics Treatment Methods ECG Tests Coronary Heart Disease Heart Attack Causes Cardiac Events Ambulatory Care ARNI and SGLT2 Inhibitors Biomarkers Cholesterol Levels Coronary Microvascular Dysfunction Valvular Heart Disease Cardiomyocyte Patches Muscle Patches Diagnosis Heart Scans Awareness Campaigns Cholesterol management Medical Professionals Women's Health Symptoms

Mounjaro Study Finds Lower Heart‑Attack Risk as UK Safety Reports Rise

Officials say Yellow Card reports do not prove drugs caused harm.

FDA Staff Flags Major Flaws in Capricor’s Deramiocel Data

FDA Approves First Oral PCSK9 Pill, Merck’s Lipfendra

Dapagliflozin Cuts Heart-Failure Hospitalizations by About 80% in People With Cardiomyopathy Genes

Single Infusion Gene Editing Lowers LDL by Up to 62% in Early Trial

New U.S. Cholesterol Guideline Shifts Prevention Earlier, Endorses PREVENT and Clear LDL Goals

University of Michigan AI Detects Microvascular Heart Disease From a 10-Second EKG

Abdominal Fat, Not BMI, Linked to Harmful Heart Remodeling in MRI Study

Merck’s Oral PCSK9 Pill Matches Injectables in Phase 3, Setting Up 2026 FDA Bid

Personalized Vitamin D Strategy Halves Risk of Repeat Heart Attack in Randomized Trial

Three-Biomarker Panel Flags Nearly Triple Heart Attack Risk in AHA 2025 Study

Large Wearable Study Ties Nighttime Light to Higher Heart Disease Risk

ACC Issues Scientific Statement on Inflammation in Heart Disease, Endorsing hsCRP for Risk Assessment

AI Uses Mammograms to Predict Women’s Cardiovascular Risk

Study Finds Most Heart Attacks in Younger Women Are Not From Blocked Arteries

AstraZeneca’s Baxdrostat Lowers Blood Pressure in Phase III, Setting Up 2025 Filings

AI ECG Screening Tools Enter Clinical Trials After Outperforming Doctors

Atrial Fibrillation at Time of Mitral Edge-to-Edge Repair Doubles Risk of Death or Rehospitalization

New Study Probes AIMP3 Boost to Shield Heart From Damage